MGST1 drives lymph node metastasis in papillary thyroid carcinoma via mitochondrial metabolic reprogramming and immune suppression.
Saved in:
| Title: | MGST1 drives lymph node metastasis in papillary thyroid carcinoma via mitochondrial metabolic reprogramming and immune suppression. |
|---|---|
| Authors: | Wang QX; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China., Yu CF; School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China., Zhang KC; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Zhang JH; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Zhou XJ; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Zou TX; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Huang HZ; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Han TY; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Mei HZ; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., Su KB; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang, China., You J; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China., Qu JM; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China., Xie C; Department of General Surgery, Zhejiang Dinghai Hospital, Shanghai Ruijin Hospital Zhoushan Branch, Zhoushan, Zhejiang, China., Li Q; Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China., Cai YF; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 04; Vol. 17, pp. 1848083. Date of Electronic Publication: 2026 Jun 04 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1848083 |
